A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...
The treatment also prevented the development of arthritis after knee injuries such as ACL tears often experienced by athletes ...
Scientists at Stanford Medicine have reported a discovery that could change how arthritis and joint damage are treated. In experiments on animals and human tissue, researchers found that blocking a ...
Knee cartilage usually wears down quietly. Over time, that loss can turn walking stairs into a daily calculation. Now a ...
Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical ...
Regentis Biomaterials Ltd ( ($RGNT) ) has shared an announcement. On January 6, 2025, Regentis Biomaterials announced peer-reviewed publication of ...
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical trial, as a predefined endpointNew peer-reviewed data published in the scientifi ...
I write further to the recent public discourse surrounding the Presidential Task Force appointed to oversee rehabilitation, ...
Joshua Cox-Steib is a sociologist and freelance writer. He lives in Tulsa, Oklahoma, with his wife and their menagerie of pets. Joshua holds a degree in sociology from the University of Tulsa and ...